Beta Cyclodextrin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Customs duty relief for Covid tangled in red tape × The on-going second wave of Covid-19 has taken many by surprise including the Central Board of Indirect Taxes and Customs (CBIC). The second wave has hit India so hard that beds in hospitals are hard to get, beds with oxygen are next to impossible and there is a huge shortage of vaccines. Importing these things seems to be the only option. But, CBIC would levy both Customs Duty and Integrated Goods and Service Tax (IGST) on such imports thereby making the landed cost higher. After a bit of back and forth, CBIC responded. On April 20 and 24...

Remdesivir production capacity ramped up to 1.19 crore vials per month: Centre To augment the domestic production capacity, all the seven manufacturers of remdesivir in the country were asked to ramp up production quickly, the ministry said in a statement PTI | May 18, 2021 | Updated 13:00 IST The production capacity of remdesivir used for the treatment of COVID-19 has increased from 38 lakh vials per month to nearly 1.19 crore vials per month, the Ministry of Chemicals and Fertilizers said on Monday. Remdesivir is manufactured in India under voluntary licenses granted by Gilead Life Science...

COVID-19: Production capacity of Remdesivir increased to nearly 119 lakh vials per month, says Govt ANI | Updated: May 17, 2021 17:33 IST New Delhi [India], May 17 (ANI): With the sudden increase of cases during the second wave of the pandemic, the government has taken swift actions to enhance the availability of an anti-viral drug Remdesivir across the country. Presently, nearly 119 lakh vials of Remdesivir are being produced per month, the Department of Pharmaceuticals informed on Monday. The department has, ever since, intensified the monitor on the av...

Remdesivir production capacity increased to around 1.19 cr crore vials a month: Govt New Delhi : The production capacity of remdesivir used for the treatment of COVID-19 has increased from 38 lakh vials per month to nearly 1.19 crore vials per month, the Ministry of Chemicals and Fertilizers said on Monday. Remdesivir is manufactured in India under voluntary licenses granted by Gilead Life Sciences to 7 pharmaceutical companies — Cipla, Dr Reddy”s, Hetero, Jubilant Pharma, Mylan, Syngene and Zydus Cadila, it added. To augment the domestic production capacity, all the seven manufacturers o...

To augment the domestic production capacity, all the seven manufacturers of remdesivir in the country were asked to ramp up production quickly, the ministry said in a statement. "With the combined efforts of the central government and the manufacturing companies, the production capacity of the licensed manufacturers has increased unprecedentedly from 38 lakh vials per month to nearly 119 lakh vials per month," it added.